RSV vaccines – ACIP recommends expanded use in 50 – 59 years of age
April 16, 2025 - The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted 14 to zero with one abstention that adults 50 – 59 years of age who are at increased risk of severe respiratory syncytial virus (RSV) disease receive a single dose of RSV vaccine.
Top